Skip to main content
Tech.euFundingExplorerBeta

Cimeio Therapeutics

Basel, Switzerland- and Boston, MA-based biotechnology company developing a novel approach to cell therapies

Cimeio Therapeutics has raised €328M across 2 funding rounds from 2 investors, most recently a round in Dec 2024. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€328M
€328,183,454
Funding rounds
2
Investors
2
distinct backers
Active since
2022-04
latest 2024-12

Funding by year

EUR raised per year
Cimeio Therapeutics — funding by year — interactive chart.
Data table
Cimeio Therapeutics — funding by year
2022€46M
2024€282M

Signals

High confidence
Raise-next likelihood34
base rate 30% for Other
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2024-12-12Other€282MKyowa KirinView deal →
2022-04-18Series A€46MVersant VenturesView deal →

Similar companies

same sector or country

Global coverage: FundingData